Core Laboratories N.V. Common SharesNLG (CLB) CEO David M Demshur sells 150,000 Shares

CEO of Core Laboratories N.V. Common SharesNLG (CLB, Financial) David M Demshur sells 150,000 shares of CLB on 02/16/2010 at an average price of $123.35 a share.

Core Laboratories N.v. Common Sharesnlg has a market cap of $2.83 billion; its shares were traded at around $122.94 with a P/E ratio of 24.7 and P/S ratio of 4.1. The dividend yield of Core Laboratories N.v. Common Sharesnlg stocks is 0.4%. Core Laboratories N.v. Common Sharesnlg had an annual average earning growth of 14.2% over the past 10 years.

CLB is in the portfolios of Richard Aster Jr of Meridian Fund, Ron Baron of Baron Funds, RS Investment Management, Chuck Royce of ROYCE & ASSOCIATES.

CEO Recent Trades:

  • Sell:: President & CEO David M Demshur sold 100,000 shares of CLB stock on 10/29/2009 at the average price of 107.5, the price of the stock has increased by 14.36% since.



CFO Recent Trades:

  • Sell:: EVP, CFO & Treasurer Richard L Bergmark sold 50,000 shares of CLB stock on 11/02/2009 at the average price of 104.96, the price of the stock has increased by 17.13% since.



Directors and Officers Recent Trades:

  • Buy:: VP, Counsel & Secretary Mark F Elvig bought 200 shares of CLB stock on 10/27/2009 at the average price of 109.24, the price of the stock has increased by 12.54% since.

  • Sell:: Director Joseph R Perna sold 11,990 shares of CLB stock on 11/09/2009 at the average price of 110.08, the price of the stock has increased by 11.68% since.

  • Sell:: Director Rene R Joyce sold 7,000 shares of CLB stock on 11/09/2009 at the average price of 110.29, the price of the stock has increased by 11.47% since.

  • Sell:: COO Monty L Davis sold 17,778 shares of CLB stock on 11/02/2009 at the average price of 104.4, the price of the stock has increased by 17.76% since.

  • Sell:: VP & CAO Charles Brigham Miller sold 26,838 shares of CLB stock on 10/28/2009 at the average price of 112.45, the price of the stock has increased by 9.33% since.